Canaccord Genuity Group reiterated their hold rating on shares of Inari Medical (NASDAQ:NARI – Free Report) in a research ...

Fintel reports that on January 7, 2025, Canaccord Genuity initiated coverage of Rollins (NYSE:ROL) with a Hold recommendation ...

SolarEdge Technologies (NASDAQ:SEDG – Free Report) had its price target increased by Canaccord Genuity Group from $16.00 to $18.00 in a research report released on Tuesday,Benzinga reports. They ...

Fintel reports that on January 7, 2025, Canaccord Genuity downgraded their outlook for Inari Medical (NasdaqGS:NARI) from Buy ...

Canaccord Genuity analyst Kai Korschelt reiterated a Buy rating on Zegona Communications (ZEG – Research Report) today and set a price target ...

Clover Health Investments Corp (CLOV) stock saw a modest uptick, ending the day at $3.6 which represents a slight increase of $0.22 or 6.51% from the prior close of $3.38. The stock opened at $3.38 ...

Jefferies has recently raised Bark Inc (BARK) stock to Buy rating, as announced on March 5, 2024, according to Finviz. Earlier, on December 19, 2023, Jefferies had initiated the stock to Hold, setting ...

Canaccord Genuity maintained its price target on Antofagasta on Monday at 2,065p on the back of improving year-on-year profit ...

In this week’s episode, Cam Currie, Senior Investment Advisor at Canaccord Genuity and founder of Currie Metals and Mining Group, joins Adrian Pocobelli to analyze the performance of gold ...

Reston energy consulting firm ICF International Inc., one of the region's largest government tech contractors, has made ...

Canaccord Genuity raised its price target on Tesla (TSLA) to $404 per share from $298, citing optimism over the company’s growth, including in its energy business and possible robotics venture. Market ...

Analyst Whitney Ijem from Canaccord Genuity maintained a Buy rating on Arcturus Therapeutics (ARCT – Research Report) and keeping the price ...